Cas:52747-01-0 3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene manufacturer & supplier

Chemical Name:3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene

CAS.NO:52747-01-0

Synonyms:3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol;Propanol,((1-methyl-1,2-ethanediyl)bis(oxy))bis-,polymer with 1,1′-methylenebis(4-isocyanatobenzene);Benzene,1,1′-methylenebis(4-isocyanato-,polymer with propanol,((1-methyl-1,2-ethanediyl)bis(oxy)bis

Molecular Formula:C₂₄H₃₀N₂O₆

Molecular Weight:442.50500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:373.4ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:117.78000

Exact Mass:442.21000

LogP:3.38490

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene,1,1′-methylenebis(4-isocyanato-,polymer with propanol,((1-methyl-1,2-ethanediyl)bis(oxy)bis physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Propanol,((1-methyl-1,2-ethanediyl)bis(oxy))bis-,polymer with 1,1′-methylenebis(4-isocyanatobenzene) Use and application,Benzene,1,1′-methylenebis(4-isocyanato-,polymer with propanol,((1-methyl-1,2-ethanediyl)bis(oxy)bis technical grade,usp/ep/jp grade.

Related News: Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. 3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene manufacturer The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. 3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene supplier The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. 3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene vendor The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. 3-[2-(3-hydroxypropoxy)propoxy]propan-1-ol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene factory The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.